MM-433593

CAS No. 1006604-91-6

MM-433593( —— )

Catalog No. M34337 CAS No. 1006604-91-6

MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
100MG 2250 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MM-433593
  • Note
    Research use only, not for human use.
  • Brief Description
    MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.
  • Description
    MM-433593 is a selective fatty acid amide hydrolase (FAAH-1) inhibitor for the treatment of pain, inflammation, and other disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FAAH
  • Recptor
    FAAH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1006604-91-6
  • Formula Weight
    447.91
  • Molecular Formula
    C25H22ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC=1C=CN=C(OC)C1)C(=O)C=2C=3C=C(C=CC3N(C2C)CC4=CC=C(Cl)C=C4)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • FAAH inhibitor 1

    FAAH inhibitor 1 is an effective FAAH inhibitor with an IC50 of 18 nM.

  • Dual FAAH/sEH-IN-1

    Dual FAAH/sEH-IN-1 is a dual inhibitor of sEH (soluble epoxide hydrolase) (IC50: 9.6 nM) and FAAH (fatty acid amide hydrolase) (IC50: 7 nM) with high affinity and anti-inflammatory activity.

  • URB-597

    A potent and selective FAAH inhibitor with IC50 of 4.6 nM; increases anandamide levels in the brain of rats and wild-type mice (0.3 mg/kg i.p.); improves cognitive impairment by inhibiting mTOR-dependent autophagy in a CCH model.